Methotrexato Teva

Methotrexate, the active ingredient in Methotrexato Teva, is an antifolate presented as an injectable solution for epidural, intra‑articular and intramuscular use. It is employed to treat certain autoimmune disorders and selected cancers in adult patients. It is indicated for conditions where suppression of abnormal cell proliferation is required.

GNH USA supplies Methotrexato Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

Methotrexate is used in several autoimmune and oncologic disease pathways to inhibit abnormal cell growth.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriasis: decreases skin cell turnover and improves plaque lesions. Acute lymphoblastic leukemia: interferes with malignant lymphoblast proliferation. Osteosarcoma: limits tumor growth by blocking DNA synthesis. Other autoimmune diseases: modulates immune response to control disease activity.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Fatigue or weakness - Mouth sores (stomatitis) - Decreased blood cell counts (e.g., neutropenia, anemia)

Serious or Rare Side Effects: - Severe liver toxicity (hepatitis, fibrosis) - Pulmonary fibrosis or interstitial pneumonitis - Life‑threatening infection due to immunosuppression

When prescribing methotrexate, clinicians should observe several safety measures to minimize risk. - Monitor liver function: perform baseline and periodic liver enzyme tests. - Monitor hematologic parameters: check complete blood count regularly. - Avoid use in pregnancy: drug is contraindicated due to teratogenic risk. - Adjust dose in renal impairment: reduce dosage or increase monitoring. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase renal toxicity and reduce clearance. - High‑dose folic acid supplements: can diminish methotrexate’s therapeutic effect.

Moderate Interactions (Monitor Closely): - Penicillins and other β‑lactam antibiotics: may raise methotrexate plasma concentrations. - Proton pump inhibitors (e.g., omeprazole): can increase methotrexate toxicity. - Live vaccines: immunosuppression raises risk of infection.